Profil Institute: Advancing Clinical Research for Diabetes, Obesity and Cardiometabolic Diseases
Profil Institute is a Center of Excellence for diabetes and obesity early phase clinical research. The company’s advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be a highly regarded clinical research institute for early phase diabetes drug trials.
Profil Institute has been involved with every clinically promising drug class and device development in diabetes and in more than 200 clinical studies since the company’s inception in 2004. Contributing to Profil Institute’s success is that the company is recognized as the leader in automated glucose clamps, considered the “Gold Standard” for the evaluation of anti-diabetic drugs and devices. The company’s key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Düsseldorf, Columbia University, University of Michigan and Harvard University.